Post-marketing studies of drug efficacy: How?
- 1 October 1984
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 77 (4) , 703-708
- https://doi.org/10.1016/0002-9343(84)90369-3
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Postmarketing studies of drug efficacy: When must they be randomized?Clinical Pharmacology & Therapeutics, 1983
- The need for randomization in the study of intended effectsStatistics in Medicine, 1983
- The risk of hip fracture in postmenopausal females with or without estrogen drug exposure.American Journal of Public Health, 1981
- Can Postmarketing Surveillance Help to Effect Optimal Drug Therapy?Published by American Medical Association (AMA) ,1979
- Postmarketing Follow-upJAMA, 1979
- POST-MENOPAUSAL $OElig;STROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS A Case-control StudyThe Lancet, 1979
- Postmarketing Surveillance of New Drugs: I. Review of Objectives and MethodologyThe Journal of Clinical Pharmacology, 1979
- Drug Evaluation After MarketingAnnals of Internal Medicine, 1979
- The Discovery of Drug-Induced IllnessNew England Journal of Medicine, 1977
- The Evaluation of New DrugsArchives of internal medicine (1960), 1967